Suma Krishnan sold $9M of KRYS stock

Suma Krishnan, President, R&D, 10% of Krystal Biotech, Inc. (KRYS), sold 25,000 shares of KRYS stock worth $9M, per an SEC Form 4 filed Sep 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Sep 4, 2026.

KRYS has moved -14.7% since the trade date, from $358.24 to $305.68 (Nov 12, 2026 close).